Åsa Mackenzie

Senior Lecturer

Lund University
Country flagSweden

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Åsa Mackenzie is a Professor and Chair in Molecular Physiology at Uppsala University, Sweden. She leads the Unit of Comparative Physiology and her research focuses on neuromodulation, optogenetics, and the architecture of the subthalamic nucleus. Recent articles include studies on brain stimulation protocols in mouse models and their implications for neuropsychiatric disorders. Her work contributes significantly to understanding motor control and dopamine cell heterogeneity in the context of neurodegenerative diseases.

Articles (11)

The brain area including and surrounding the subthalamic nucleus (STN) contains several targets for deep brain stimulation (DBS): dorsal STN for the treatment of motor symptoms in Parkinson’s disease (PD), anteromedial STN for obsessive compulsive disorder (OCD), zona incerta (ZI) for PD and essential tremor, and medial forebrain bundle (MFB) for OCD and depression. Despite clinical application, molecular and anatomical understanding of this area has remained elusive. To help solving this, we took advantage of our recent data from transcriptomics analysis in mice, and applied fluorescent in situ hybridization (FISH) analysis on macaque and human brain sections. In accordance with a glutamatergic phenotype, we observed VGLUT2 mRNA across the STN, with quantification revealing higher VGLUT2 density in the ventromedial (vm) STN than dorsal STN. Unexpectedly, we identified HTR2C mRNA uniquely localized to vmSTN, while absent in dorsal STN. HTR2C thereby molecularly defines a distinct vmSTN domain, hereafter named vmSTN HTR2C . Based on the role of the serotonin (5-HT) 2C receptor in mood, vmSTN HTR2C may spatio-molecularly correspond to the limbic STN. The ventralized HTR2C profile was strongest in anterior STN and coincided with serotonergic innervation. The presence of vmSTN HTR2C was identified also in the human brain, but absent in the mouse. Strong HTR2C anteriorly revealed a new “far-anterior” STN domain. Comparing HTR2C with TAC1 , a para-STN marker, para-STN was identified at the anterior STN, partly intermingled with the MFB. Thus, anterior STN shows several unique molecular and anatomical features in the primate brain. Upon analysis of multiple markers, the STN, para-STN and ZI could be divided into several expression-based domains, which we used to construct molecularly supported anatomical maps. This data will inform neuromodulation strategies, such as DBS, and pharmacological treatment approaches.

Year:

2025

Year:

2024

Year:

2024

The subthalamic nucleus (STN) is a major neuromodulation target for the alleviation of neurological and neuropsychiatric symptoms using deep brain stimulation (DBS). STN-DBS is today applied as treatment in Parkinson´s disease, dystonia, essential tremor, and obsessive-compulsive disorder (OCD). STN-DBS also shows promise as a treatment for refractory Tourette syndrome. However, the internal organization of the STN has remained elusive and challenges researchers and clinicians: How can this small brain structure engage in the multitude of functions that renders it a key hub for therapeutic intervention of a variety of brain disorders ranging from motor to affective to cognitive? Based on recent gene expression studies of the STN, a comprehensive view of the anatomical and cellular organization, including revelations of spatio-molecular heterogeneity, is now possible to outline. In this review, we focus attention to the neurobiological architecture of the STN with specific emphasis on molecular patterns discovered within this complex brain area. Studies from human, non-human primate, and rodent brains now reveal anatomically defined distribution of specific molecular markers. Together their spatial patterns indicate a heterogeneous molecular architecture within the STN. Considering the translational capacity of targeting the STN in severe brain disorders, the addition of molecular profiling of the STN will allow for advancement in precision of clinical STN-based interventions.

Year:

2024

The ventromedial subthalamic nucleus (STN) is associated with affective function via limbic brain networks. Clinical data indicate the anterior aspect of ventromedial STN as an important target in Deep brain stimulation (DBS) intervention of psychiatric disorder, including Obsessive-compulsive disorder (OCD), for which Selective serotonin reuptake inhibitors (SSRIs) are prescribed. However, far from all patients respond to either SSRIs or DBS. Despite clinical relevance, the primate STN is lacking in molecular and anatomical detail. Here, transcriptome data generated in mice was implemented in comparative analysis with macaque and human. Remarkable species differences were observed. Serotonin receptor 2c (HTR2C) mRNA was identified in a distinct ventromedial STN profile in macaque and human, non-paralleled in mouse. This included the medial tip and anteromedial STN, where HTR2C was distributed in patterns matching reports of serotonergic innervation. In primates, but not mice, a previously undescribed far-anterior STN brain area was uncovered, and the anterior, but not posterior, STN was found to border the hypothalamic para-STN. In both mice and primates, gradients of HTR2C mRNA allowed para-STN to be subdivided into core and shell domains. Dorsal to STN, para-STN was partly embedded in the Medial forebrain bundle (MFB), a DBS target in OCD and depression. Transcriptome data visualized in serial sections and 3D brain fly-through videos challenge current atlases of STN, pSTN, and MFB anatomy in mice and primates. Differential mRNA patterns in the primate, including unique HTR2C profiles, may provide openings for drug discovery and enhanced anatomical precision, and uncover neurobiological underpinnings of psychiatric disorders.

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Asheeta Prasad

ARC Discovery Early Career Researcher

University of New South Wales

AUSTRALIA
View details

Carine Karachi

Sorbonne Université

FRANCE
View details

Martin Ingelsson

Specialist

Uppsala University Hospital

SWEDEN
View details